192 related articles for article (PubMed ID: 8607184)
1. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody.
Orosz CG; Wakely E; Bergese SD; VanBuskirk AM; Ferguson RM; Mullet D; Apseloff G; Gerber N
Transplantation; 1996 Mar; 61(5):783-91. PubMed ID: 8607184
[TBL] [Abstract][Full Text] [Related]
2. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
[TBL] [Abstract][Full Text] [Related]
3. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
4. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
VanBuskirk AM; Wakely ME; Sirak JH; Orosz CG
Transplantation; 1998 Apr; 65(8):1115-23. PubMed ID: 9583874
[TBL] [Abstract][Full Text] [Related]
5. Local cellular immunology of experimental transplant vascular sclerosis.
Orosz CG
Clin Transplant; 1996 Feb; 10(1 Pt 2):100-3. PubMed ID: 8680044
[TBL] [Abstract][Full Text] [Related]
6. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.
Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS
Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762
[TBL] [Abstract][Full Text] [Related]
7. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis in murine cardiac grafts.
Bergese SD; Klenotic SM; Wakely ME; Sedmak DD; Orosz CG
Transplantation; 1997 Jan; 63(2):320-5. PubMed ID: 9020338
[TBL] [Abstract][Full Text] [Related]
9. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection.
Bergese SD; Huang EH; Pelletier RP; Widmer MB; Ferguson RM; Orosz CG
Am J Pathol; 1995 Jul; 147(1):166-75. PubMed ID: 7541609
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
11. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
Hancock WW; Sayegh MH; Sablinski T; Kut JP; Kupiec-Weglinski JW; Milford EL
Transplantation; 1992 Jun; 53(6):1276-80. PubMed ID: 1604485
[TBL] [Abstract][Full Text] [Related]
12. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
[TBL] [Abstract][Full Text] [Related]
13. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo.
Pelletier RP; Ohye RG; Vanbuskirk A; Sedmak DD; Kincade P; Ferguson RM; Orosz CG
J Immunol; 1992 Oct; 149(7):2473-81. PubMed ID: 1382105
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
[TBL] [Abstract][Full Text] [Related]
15. Survival, function, morphology and serological aspects of rat renal allografts. Effect of short-term treatment with cyclosporine A, anti-CD4 and anti-interleukin-2 receptor monoclonal antibodies.
Steinbrüchel DA; Larsen S; Kristensen T; Starklint H; Koch C; Kemp E
APMIS; 1992 Aug; 100(8):682-94. PubMed ID: 1520480
[TBL] [Abstract][Full Text] [Related]
16. Cardiac allograft tolerance: failure to develop in interleukin-4-deficient mice correlates with unusual allosensitization patterns.
Sirak JH; Orosz CG; Roopenian DC; Wakely E; VanBuskirk AM
Transplantation; 1998 May; 65(10):1352-6. PubMed ID: 9625018
[TBL] [Abstract][Full Text] [Related]
17. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplants recipients.
Han WR; Murray-Segal LJ; Mottram PL
Transpl Immunol; 1999 Mar; 7(1):37-44. PubMed ID: 10375076
[TBL] [Abstract][Full Text] [Related]
18. Treatment with anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance.
Orosz CG; Ohye RG; Pelletier RP; Van Buskirk AM; Huang E; Morgan C; Kincade PW; Ferguson RM
Transplantation; 1993 Aug; 56(2):453-60. PubMed ID: 7689262
[TBL] [Abstract][Full Text] [Related]
19. Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations.
Qi Z; Riesbeck K; Ostraat O; Tufveson G; Ekberg H
Transpl Immunol; 1997 Sep; 5(3):204-11. PubMed ID: 9402687
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
